A Study of Mirikizumab (LY3074828) in Pediatric Participants With Moderately to Severely or Active Ulcerative Colitis
Completed · Phase 3 · NCT05784246
Conditions: Ulcerative Colitis
At a glance
- Research payments reported, 2025
- $338,036
- U.S. investigators named
- 12
- Sites paid
- 12
- Planned or actual enrollment
- 63
About the trial
- Sponsor
- Eli Lilly and Company
- Tested
- Mirikizumab IV (drug), Mirikizumab SC (drug)
- Dates
- Started 2023-11-22; completion 2026-05-01
- Results posted
- Not yet
The main purpose of this study is to investigate efficacy, pharmacokinetics and safety of the drug in pediatric participants with moderately to severely active ulcerative colitis (UC).
From ClinicalTrials.gov, last updated 2026-06-03. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Eli Lilly and Company reported $338,036 in research payments for this study in 2025 (14 payments).
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Jeannie S. Huang, M.D. Pediatric Gastroenterology · San Diego, CA
- Sofia G. Verstraete, M.D. Student in an Organized Health Care Education/Training Program · San Francisco, CA
- Jeffrey S. Hyams, MD Pediatric Gastroenterology · Hartford, CT
- Jeffery D. Lewis, MD Pediatric Gastroenterology · Atlanta, GA
- Steven J. Steiner, MD Pediatric Gastroenterology · Indianapolis, IN
- Athos Bousvaros, MD, MPH Pediatric Gastroenterology · Boston, MA
- Jess L. Kaplan, MD Pediatrics · Boston, MA
- Charles M. Samson, MD Pediatric Gastroenterology · Saint Louis, MO
- Oren Koslowe Pediatric Gastroenterology · Morristown, NJ
- David S. Dunkin, M.D. Pediatric Gastroenterology · New York, NY
- Phillip P. Minar, M.D. Pediatric Gastroenterology · Cincinnati, OH
- Michael J. Dougherty, D.O. Pediatric Gastroenterology · Greenville, SC
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- Washington University $65,037
- Childrens Center for Digestive Health Care LLC $49,139
- Cincinnati Children's Hospital Medical Center, OH $48,869
- Boston Children's Hospital, MA $37,350
- UCSF Langley Porter Psychiatric Hospital and Clinics, CA $33,039
- Prisma Health Oconee Memorial Hospital, SC $27,650
- Regents of the University of California $21,252
- Mount Sinai School of Medicine $20,567
- Indiana University $14,684
- Connecticut Childrens Medical Center, CT $13,500
- Massachusetts General Hospital, MA $5,050
- Morristown Medical Center, NJ $1,274
- $625
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.